CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors

Author(s)
Wang, Dan; Zhang, Feng; Gao, Guangping
Thumbnail
DownloadAccepted version (965.0Kb)
Publisher with Creative Commons License
Terms of use
Creative Commons Attribution-NonCommercial-NoDerivs License http://creativecommons.org/licenses/by-nc-nd/4.0/
Metadata
Show full item record
Abstract
© 2020 Elsevier Inc. Wang, Zhang, and Gao discuss the progress, concerns, and challenges currently facing CRISPR-based therapeutics, a field that has inspired renewed but cautious interest in human genome editing.
Date issued
2020-04
URI
https://hdl.handle.net/1721.1/138388.2
Department
Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences; Massachusetts Institute of Technology. Department of Biological Engineering; McGovern Institute for Brain Research at MIT; Howard Hughes Medical Institute
Journal
Cell
Publisher
Elsevier BV
Citation
Wang, D, Zhang, F and Gao, G. 2020. "CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors." Cell, 181 (1).
Version: Author's final manuscript
ISSN
0092-8674
Collections

Version History

VersionItemDateSummary
21721.1/138388.2*2022-05-16T19:29:49ZPublication information verified/added.
11721.1/1383882021-12-08T18:08:11Z

*Selected version